KDIGO 53-58
KDIGO Renal & Diabetes Quiz
Test your knowledge on the management of patients with chronic kidney disease (CKD) and diabetes. This quiz covers essential aspects of pharmacotherapy and clinical guidelines related to kidney fun
- 5 multiple-choice questions
- Focus on real-world clinical applications
- Improve your understanding of CKD and diabetes management
In UKPDS metformin: (alegeti afirmatia falsa)
Cei pe metformin nu au avut crestere in greutate sau au avut dar foarte putin
Scade Hba1c similar cu insulina
Scade HbA1c mai mult decat insulina
Scade HbA1c mai mult decat iDDP4
In pre- si in dializa se pot administra urmatoarele, cu exceptia
SU
TZD
IDDP4
Insulina
Cum abordam un pacient cu BRC insa nou diagnosticat cu DZ si cu eRFG peste 30?
Initiem iSGLT2 in prima faza apoi metformin pentru o scadere cat mai rapida a riscului de progresie al bolii renale
Prima linie de tratament: metformin
Daca are IMC peste 30, prima linie de tratament GLP1-RA apoi iSGLT2 apoi metformin
Incepem cu doza maxima tolerata de metformin si de iSGT2
Daca avem un pacient cu BRC si albuminurie, care dintre cele doua iSGLT2 preferam. Alegeti varianta cu iSGLT2 care are mai multe sageti in jos la albuminurie (din studii- EMPA REG OUTCOME si DECLARE TIMI 58)
Empaglifozin
Dapaglifozin
Care este medicamentul mai putin potrivit la un pacient cu BRC si risc cardio-vascular inalt si foarte inalt
TZD
ISGLT2
GLP1RA
Metformin
{"name":"KDIGO 53-58", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"Test your knowledge on the management of patients with chronic kidney disease (CKD) and diabetes. This quiz covers essential aspects of pharmacotherapy and clinical guidelines related to kidney function and glucose control.5 multiple-choice questionsFocus on real-world clinical applicationsImprove your understanding of CKD and diabetes management","img":"https:/images/course2.png"}